BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

604 related articles for article (PubMed ID: 30571283)

  • 1. Isometric resistance training increases strength and alters histopathology of dystrophin-deficient mouse skeletal muscle.
    Lindsay A; Larson AA; Verma M; Ervasti JM; Lowe DA
    J Appl Physiol (1985); 2019 Feb; 126(2):363-375. PubMed ID: 30571283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contractile efficiency of dystrophic mdx mouse muscle: in vivo and ex vivo assessment of adaptation to exercise of functional end points.
    Capogrosso RF; Mantuano P; Cozzoli A; Sanarica F; Massari AM; Conte E; Fonzino A; Giustino A; Rolland JF; Quaranta A; De Bellis M; Camerino GM; Grange RW; De Luca A
    J Appl Physiol (1985); 2017 Apr; 122(4):828-843. PubMed ID: 28057817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neopterin/7,8-dihydroneopterin is elevated in Duchenne muscular dystrophy patients and protects mdx skeletal muscle function.
    Lindsay A; Schmiechen A; Chamberlain CM; Ervasti JM; Lowe DA
    Exp Physiol; 2018 Jul; 103(7):995-1009. PubMed ID: 29791760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy.
    Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS
    Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Truncated dystrophins reduce muscle stiffness in the extensor digitorum longus muscle of mdx mice.
    Hakim CH; Duan D
    J Appl Physiol (1985); 2013 Feb; 114(4):482-9. PubMed ID: 23221959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Xanthine oxidase is hyper-active in Duchenne muscular dystrophy.
    Lindsay A; McCourt PM; Karachunski P; Lowe DA; Ervasti JM
    Free Radic Biol Med; 2018 Dec; 129():364-371. PubMed ID: 30312761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ryanodine channel complex stabilizer compound S48168/ARM210 as a disease modifier in dystrophin-deficient mdx mice: proof-of-concept study and independent validation of efficacy.
    Capogrosso RF; Mantuano P; Uaesoontrachoon K; Cozzoli A; Giustino A; Dow T; Srinivassane S; Filipovic M; Bell C; Vandermeulen J; Massari AM; De Bellis M; Conte E; Pierno S; Camerino GM; Liantonio A; Nagaraju K; De Luca A
    FASEB J; 2018 Feb; 32(2):1025-1043. PubMed ID: 29097503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dystrophin-negative slow-twitch soleus muscles are not susceptible to eccentric contraction induced injury over the lifespan of the
    Kiriaev L; Kueh S; Morley JW; Houweling PJ; Chan S; North KN; Head SI
    Am J Physiol Cell Physiol; 2021 Oct; 321(4):C704-C720. PubMed ID: 34432537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of weakness in Mdx muscle following in vivo eccentric contractions.
    Baumann CW; Ingalls CP; Lowe DA
    J Muscle Res Cell Motil; 2022 Jun; 43(2):63-72. PubMed ID: 35445349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanics of dystrophin deficient skeletal muscles in very young mice and effects of age.
    Lopez MA; Bontiff S; Adeyeye M; Shaibani AI; Alexander MS; Wynd S; Boriek AM
    Am J Physiol Cell Physiol; 2021 Aug; 321(2):C230-C246. PubMed ID: 33979214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-intensity interval training in the form of isometric contraction improves fatigue resistance in dystrophin-deficient muscle.
    Yamauchi N; Tamai K; Kimura I; Naito A; Tokuda N; Ashida Y; Motohashi N; Aoki Y; Yamada T
    J Physiol; 2023 Jul; 601(14):2917-2933. PubMed ID: 37184335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy.
    Siemionow M; Langa P; Brodowska S; Kozlowska K; Zalants K; Budzynska K; Heydemann A
    Stem Cell Rev Rep; 2022 Dec; 18(8):2872-2892. PubMed ID: 35590083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Akt activation prevents the force drop induced by eccentric contractions in dystrophin-deficient skeletal muscle.
    Blaauw B; Mammucari C; Toniolo L; Agatea L; Abraham R; Sandri M; Reggiani C; Schiaffino S
    Hum Mol Genet; 2008 Dec; 17(23):3686-96. PubMed ID: 18753145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Consequence of parvalbumin deficiency in the mdx mouse: histological, biochemical and mechanical phenotype of a new double mutant.
    Raymackers JM; Debaix H; Colson-Van Schoor M; De Backer F; Tajeddine N; Schwaller B; Gailly P; Gillis JM
    Neuromuscul Disord; 2003 Jun; 13(5):376-87. PubMed ID: 12798793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Muscle specific kinase protects dystrophic mdx mouse muscles from eccentric contraction-induced loss of force-producing capacity.
    Trajanovska S; Ban J; Huang J; Gregorevic P; Morsch M; Allen DG; Phillips WD
    J Physiol; 2019 Sep; 597(18):4831-4850. PubMed ID: 31340406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The X-linked Becker muscular dystrophy (bmx) mouse models Becker muscular dystrophy via deletion of murine dystrophin exons 45-47.
    Heier CR; McCormack NM; Tully CB; Novak JS; Newell-Stamper BL; Russell AJ; Fiorillo AA
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):940-954. PubMed ID: 36628607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Valproic acid reduces muscle susceptibility to contraction-induced functional loss but increases weakness in two murine models of Duchenne muscular dystrophy.
    Moutachi D; Lemaitre M; Delacroix C; Agbulut O; Furling D; Ferry A
    Clin Exp Pharmacol Physiol; 2023 Sep; 50(9):749-756. PubMed ID: 37381823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanical factors tune the sensitivity of mdx muscle to eccentric strength loss and its protection by antioxidant and calcium modulators.
    Lindsay A; Baumann CW; Rebbeck RT; Yuen SL; Southern WM; Hodges JS; Cornea RL; Thomas DD; Ervasti JM; Lowe DA
    Skelet Muscle; 2020 Feb; 10(1):3. PubMed ID: 32007101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variable cytoplasmic actin expression impacts the sensitivity of different dystrophin-deficient mdx skeletal muscles to eccentric contraction.
    Lindsay A; Southern WM; McCourt PM; Larson AA; Hodges JS; Lowe DA; Ervasti JM
    FEBS J; 2019 Jul; 286(13):2562-2576. PubMed ID: 30942954
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utrophin haploinsufficiency does not worsen the functional performance, resistance to eccentric contractions and force production of dystrophic mice.
    Boulanger Piette A; Hamoudi D; Marcadet L; Kyomi Labelle F; Ovidiu David R; Bossé S; Argaw A; Frenette J
    PLoS One; 2018; 13(6):e0198408. PubMed ID: 29879154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.